DeSoto County residents filled Silo Square on Saturday for the fourth annual Blues for the Blue fundraiser, beginning with a ...
MarketBeat on MSN
Crane NXT Q1 earnings call highlights
Crane Stock Soars, But the Best Could Be Yet to Come: Here's Why Crane NXT (NYSE:CXT) reported first-quarter 2026 sales ...
Woodland Recovery Center welcomed first responders, community leaders, and local partners Wednesday during a special tour of ...
Hosted on MSN
Mastering discrete trial training in ABA practice
Discrete Trial Training (DTT) is a structured instructional method in Applied Behavior Analysis that teaches skills by breaking them into smaller, manageable steps. It is recognized as an ...
WASHINGTON, April 28 (Reuters) - The U.S. Food and Drug Administration launched a pilot program on Monday aimed at allowing the agency to monitor clinical trial data in real time, a step the agency ...
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
Previous Trial Coverage: Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | Day 8 | Day 9-11 | Day 12 | Day 13 | Day 14 | Day 15 | Day 16 | Day 17 | Day 18 | Day 19 | Day 20 Prosecutors rested ...
An anesthesiologist accused of trying to kill his wife during a cliffside hike last year in Hawaii was found guilty of the lesser charge of attempted manslaughter based on extreme mental or emotional ...
The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities for fiscal year 2027. The budget request totals $7.2 billion, including $3.3 ...
LOS ANGELES (AP) — After about a month of hearing from addiction experts, therapists, platform engineers and executives, including Mark Zuckerberg, 12 jurors are listening to closing arguments before ...
CEO Matthew Kapusta opened the call by emphasizing uniQure’s enduring focus on advancing gene therapies, highlighting "groundbreaking 3-year data from our Phase I/II study of AMT-130," which ...
Just months after laying off a quarter of its workforce to fund a phase 2 study of its bloodstream infection preventive treatment, Seres Therapeutics is pausing that investment and sending more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results